Table 1.
Characteristic | Values | |
---|---|---|
Age (year) | 65.7 ± 11.0 | |
Gender (male/female) | 124/29 | |
T stage | T1 | 14 (9%) |
T2 | 60 (39%) | |
T3 | 33 (22%) | |
T4 | 46 (30%) | |
N stage | N0 | 44 (29%) |
N1 | 15 (10%) | |
N2 | 91 (59%) | |
N3 | 3 (2%) | |
M stage | M0 | 153 (100%) |
Stage | I | 11 (7%) |
II | 22 (14%) | |
III | 17 (11%) | |
IV | 103 (67%) | |
Tumor sites | Tongue | 32 (21%) |
Nasopharynx | 9 (6%) | |
Oropharynx | 55 (36%) | |
Hypopharynx | 43 (28%) | |
Gingiva | 14 (9%) |
The majority of the patients (78%) had stage 3 and 4 advanced cancers.